Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OY1J
|
||||
| Former ID |
DNC007305
|
||||
| Drug Name |
7-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529860] | ||
| Formula |
C13H10N2O2
|
||||
| Canonical SMILES |
C1=CC(=CC2=C1C=CC(=O)O2)CN3C=CN=C3
|
||||
| InChI |
1S/C13H10N2O2/c16-13-4-3-11-2-1-10(7-12(11)17-13)8-15-6-5-14-9-15/h1-7,9H,8H2
|
||||
| InChIKey |
HXFIMHPPOABVMO-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [529860] | |
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
| PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
| Reactome | Endogenous sterols | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.